A new paper in Clinical Cancer Research indicates that at least some men will have a short-term bone scan “flare” as a consequence of initiation of treatment with abiraterone acetate. The clinical significance of this flare is still to be fully evaluated. … READ MORE …
Filed under: Management, Treatment | Tagged: abiraterone, bone scan, flare | 4 Comments »
Every year tens of thousands of men newly diagnosed with prostate cancer are given a bone scan (and other types of scan) as part of their “normal” diagnostic work-up. The only value of the bone scan is that it is able to identify men who already have (or at least may have evidence suggesting) actual metastatic prostate cancer to their bones at the time of diagnosis. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: bone scan, Diagnosis, guideline, work-up | 6 Comments »
This is hardly a radical new finding but yet another study has recently shown that we are over-using expensive scanning tests in the work-up of patients diagnosed with low- and intermediate-risk prostate cancer — and under-using these tests in men initially diagnosed with high-risk disease. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: bone scan, CT scan, MRI, necessary, PET scan | 1 Comment »
For some time we have been monitoring a problem with the supply of the radioisotopes used in bone scans for patients suspected to have metastatic prostate cancer to their bones. … READ MORE …
Filed under: Diagnosis, Management | Tagged: bone scan, rasdioisotope, technectium-99m | 3 Comments »
This weekend’s prostate cancer news includes information about:
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone, bisphosphonates, bone scan, endorectal MRI, jaw, ONJ, osteonecrosis | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 